Navigation Links
Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis
Date:2/8/2011

its products.

(1) Dixon et al. DAC Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009; 360: 2191-2201.

(2) Hayashi et al. Vascular access for hemodialysis. Nat Clin Pract Nephrol 2006; 2: 504-513

(3) Castner D. Recommendations for tracking arteriovenous access complications using a charting-by-exception model. Anna Journal, 1998; 25(4): 393-396.Company Contact: Margaret O'Toole Pervasis Therapeutics, Inc. 617-871-1201 motoole@pervasistx.comMedia Contact: Liz Falcone Feinstein Kean Healthcare 617-256-6622liz.falcone@fkhealth.com
'/>"/>

SOURCE Pervasis Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
2. Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence
3. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
4. Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
5. Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine
6. China Medicine Corporation Receives Manufacturing License for rADTZ
7. Johnson & Johnson Receives Approval from European Commission
8. Mylan Receives Approval for First-to-File Generic Sular® Extended-Release Tablets
9. Boca Pharmacal Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets
10. China Sky One Medical Receives Medical Industry Awards
11. Lakewood-Amedex Inc. Receives Notice of Allowance on Three US Patent Applications Relating to Treatment of Hemolytic Uremic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 Recent Highlights: ... first patient in PerClot ® IDE ... device and tissue processing company focused on cardiac and ... quarter of 2015.  Pat Mackin, Chairman, ... significant milestones regarding two of our top organizational objectives.  ...
(Date:4/28/2015)... BERLIN , April 28, 2015 ... universities of Berlin and the ... Berlin as a central research location ... of scientific, technical and medical information products and services, ... Charité, the Humboldt University (Humboldt-Universität), the Free University ...
(Date:4/28/2015)... 28, 2015  Influential proxy advisory firm Institutional ... at Gilead Sciences, a shareholder proposal asking the ... management and mitigation of the business risks associated ... of rapidly increasing U.S. drug prices and efforts ... costs. Proposal 8, Stockholder ...
Breaking Medicine Technology:CryoLife Reports First Quarter Results 2CryoLife Reports First Quarter Results 3CryoLife Reports First Quarter Results 4CryoLife Reports First Quarter Results 5CryoLife Reports First Quarter Results 6CryoLife Reports First Quarter Results 7CryoLife Reports First Quarter Results 8CryoLife Reports First Quarter Results 9Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3ISS Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment Proposal At Gilead Sciences 2ISS Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment Proposal At Gilead Sciences 3
(Date:4/28/2015)... 2015 The biologics safety testing market ... for the market include growth of the pharmaceutical and ... launches. Over the years, the number of drug approvals ... 2010, the FDA approved 225 drug applications and Health ... accounted for 3,822 of the pharmaceutical and 1,998 of ...
(Date:4/28/2015)... 2015 An Allegheny Health Network ... MD, FACS , has launched the first U.S. clinical ... matrix (ECM) can help patients who are at high ... , ECM is a complex mixture of naturally-occurring polymers ... and signals that guide cell behavior. ECM, manufactured from ...
(Date:4/28/2015)... Culver City, CA (PRWEB) April 28, 2015 ... today in the Journal of Molecular Imaging and ... with [18F]DCFPyL, a 2nd generation fluorine-18 labeled small-molecule ... at Johns Hopkins University in Baltimore, MD by ... , “This initial human evaluation of [18F]DCFPyL demonstrated ...
(Date:4/28/2015)... April 28, 2015 The buyer power ... out of 5, indicating a medium level of buyer ... and suppliers have equal power during negotiations. One factor ... than purchasing a health insurance policy from an insurance ... Humana), buyers can choose to self-fund their own policy ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Wimbledon ... which provides vascular, electrocardiogram, echocardiogram, and NCV testing, ... vascular testing to help podiatrists diagnose peripheral arterial ... to diagnose PAD without the aid of vascular ... Medical Officer at Wimbledon Health Partners. “Diminished ...
Breaking Medicine News(10 mins):Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 2Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 3Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 4Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2
... to Laurus Fully Repaid, LARGO, Fla., Oct. ... DYHP.OB) ("Dynamic"), a leading distributor in,the sports nutrition ... filed its Articles of Merger with the Florida ... of its merger with GeoPharma, Inc.,(Nasdaq: GORX ...
... Oct. 15 Speaker Nancy Pelosi,issued the following ... override,President Bush,s veto of the State Children,s Health ... in the House who have not already joined,this ... their vote,and to stand with 10 million children ...
... MINNEAPOLIS, Oct. 15 The Health Care,Compliance Association ... important compliance concerns for hospitals and for physicians,outlined ... Services Office of,Inspector General (OIG) 2008 Work Plan. ... industry., This vital two-part audio/web conference will ...
... Also Renews Commitment to Darfur, STAMFORD, Conn., Oct. ... more than $7,billion in aid to people in need ... AmeriCares President and CEO Curt Welling announced the milestone ... held at Westchester County Airport on Saturday., "I ...
... addition to Masimo Rainbow SET platform seen as having,potential clinical ... ... FRANCISCO, Oct. 15 Masimo, the inventor,of Pulse CO-Oximetry and ... independent and objective clinical study,presented today at the 2007 American ...
... of motion, study found , MONDAY, Oct. 15 ... and after surgery, helped reduce pain and promote mobility ... finding was presented Sunday at the annual meeting of ... The study, funded by drug maker Pfizer Inc., included ...
Cached Medicine News:Health News:Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma 2Health News:Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma 3Health News:Critical HCCA Web/Audio Conference Will Review Office of Inspector General Compliance Concerns Outlined in FY 2008 Work Plan 2Health News:AmeriCares Passes $7 Billion Mark in Aid Distributed 2Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 2Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 3Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 4Health News:Anti-Convulsant Aids Knee-Replacement Patients 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: